About half of the patients prescribed osteoporosis medications stop taking them within six months, a new report has found. This statistic was true for patients who were given Fosamax, Boniva, or Actonel. However, the new report did not explore the reasons that so many patients stopped treatment.
The UK, which had previously considered measures to limit the choices of medication available to osteoporosis patients, seems to be moving... Read more »
Osteoporosis can impose a number of serious challenges - a fear of fracture, back pain, and handling a treatment regimen and possibly its... Read more »
The latest news linking osteoporosis drug Fosamax - also known by its generic name alendronate - with atrial heart fibrillation in some... Read more »
Today we will be interviewing a brilliant young lady, sixteen years old, with idiopathic juvenile osteoporosis (IJO). This story will... Read more »
Work continues on alternative ways for osteoporosis patients to use parathyroid hormone to preserve (or even build) bone mass. Bone Medical... Read more »
Osteoporosis is a disease that causes bones to weaken and break. The most common bones affected are the hip, wrist and vertebrae. Approximately 10... Read more »
Osteoporosis patients who suffer a fracture are at an increased risk of dying over the next five to 10 years, a new study suggests. The Australian... Read more »
Exercise in pill form may be coming soon to osteoporosis patients, experts say. Researchers know that mechanical stress brought on by jumping,... Read more »
According to new research, doctors should require that all their osteoporosis patients take vitamin D. Scientists say their new study showed that... Read more »
Legislation designed to protect patient access to osteoporosis care has been introduced in the U.S. Congress. The Medicare Fracture Prevention and... Read more »